2017 American Transplant Congress
Role of HMG CoA Reductase Inhibitors on Time to Development of Chronic Lung Allograft Dysfunction Post-Lung Transplant.
Duke University Hospital, Durham, NC
Purpose: Five-year survival after lung transplant (LT) is approximately 55%. Chronic lung allograft dysfunction (CLAD) is a primary contributor to this reduced survival post-LT. Options…2017 American Transplant Congress
MMR and Varicella Immunity After Pediatric Liver Transplant.
1Baylor College of Medicine, Houston; 2Texas Children's Hospital, Houston
Background: Children listed for liver transplantation (LT) are at risk for decreased vaccine response due to age, underlying disease, or waning immunity. Live attenuated vaccines…2017 American Transplant Congress
Porta Systemic Shunts Helps Us to Delay or Avoid Liver Transplantation in Patients with Portal Hypertension Post Kasai Operation for Biliary Atresia.
Paediatric Surgery and Transplant Surgery, Children's Hospital at Westmead, Sydney, NSW, Australia
We present a series of 10 patients who had Kasai operation for biliary atresia in the neonatal period. These patients had optimally functioning liver in…2017 American Transplant Congress
Preservation of Musculoskeletal Components in Vascularized Composite Allograft Skin Rejection.
University of Maryland School of Medicine, Baltimore, MD
Background: Severe or chronic rejection of vascularized composite allografts (VCA) has resulted in graft loss and patient deaths. 'Split tolerance' has been defined in patterns…2017 American Transplant Congress
Development of an Anti-HLA Antibody-Producing Humanized Mouse Model.
Chronic antibody-mediated rejection due to anti-human leukocyte antigen (HLA) antibodies (Abs) is an important problem in organ transplantation. The spleen has been reported to be…2017 American Transplant Congress
A Single Center's Experience of Direct Acting Anti-Viral Agents in HCV Positive Patients Receiving an HCV Positive Kidney.
Background: Nearly 8% of patients in the U.S. undergoing hemodialysis are Hepatitis C (HCV) positive. There is a survival benefit in HCV positive patients who…2017 American Transplant Congress
Evaluation of Outcomes in Renal Transplantation Using Machine Perfusion for the Preservation of Kidneys from Expanded Criteria Donor.
Agence de la Biomedecine, Saint Denis La Plaine, France
Introduction:The shortage of kidney grafts led to retrieve organs from old donors with one or more co-morbidities, considered as “expanded criteria donors” (ECD). In France,…2017 American Transplant Congress
Transplant without Borders – A New Project for Decentralization of Transplant Centers in Brazil.
Organ Transplantation, Bandeirantes Hospital, Sao Paulo, Brazil
The regional disparity in transplant activity is one of the main problems in Brazil and in other countries. Brazilian transplant centers are concentrated in the…2017 American Transplant Congress
Protocol of the KTFT-TALK Study to Reduce Racial Disparities in Kidney Transplant Evaluation and Living Donor Kidney Transplantation.
Living donor kidney transplantation (LDKT) is the optimal treatment for end-stage kidney disease (ESKD). But, the evaluation process for a kidney transplant is complex, time…2017 American Transplant Congress
Accuracy of Computed Tomography for Detecting Hepatic Steatosis in Donors for Liver Transplantation.
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Background: The accuracy of computed tomography (CT) for detecting donor hepatic steatosis (HS) before liver transplantation is not well established.Methods: A meta-analysis was performed to…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 181
- Next Page »